SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-005352
Filing Date
2024-01-22
Accepted
2024-01-22 17:01:11
Documents
15
Period of Report
2024-01-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191960-8k_60degrees.htm   iXBRL 8-K 29406
2 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JANUARY 22, 2024 ea191960ex99-1_60degrees.htm EX-99.1 32691
7 GRAPHIC ex99-1_001.jpg GRAPHIC 5121
  Complete submission text file 0001213900-24-005352.txt   297503

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sxtp-20240122.xsd EX-101.SCH 3813
4 XBRL DEFINITION FILE sxtp-20240122_def.xml EX-101.DEF 26668
5 XBRL LABEL FILE sxtp-20240122_lab.xml EX-101.LAB 36762
6 XBRL PRESENTATION FILE sxtp-20240122_pre.xml EX-101.PRE 25292
9 EXTRACTED XBRL INSTANCE DOCUMENT ea191960-8k_60degrees_htm.xml XML 5321
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 24549558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)